Newborn Screening Reference Center
![](https://nih.upm.edu.ph/sites/default/files/nsrc.png)
Republic Act 9288 or the Newborn Screening Act of 2004 mandated the NIH to serve as the technical partner of the Department of Health (DOH) in ensuring the quality of service and sustainability of the National Comprehensive Newborn Screening System (NCNBSS). NIH performs this function through the NSRC. The establishment of NSRC, under the BOR’s approval in its 1188th meeting on October 28, 2004, marked a major initiative in addressing the needs of NCNBSS.
In its 16 years of operations, NSRC has provided technical assistance to the DOH in reaching its goal of screening Filipino newborns for common life-threatening heritable disorders. It has collaborated with the DOH in the setting-up of the necessary NBS system infrastructures – from the selection and accreditation of Newborn Screening Centers (NSCs), recruitment of health facilities to become participating Newborn Screening (NBS) facilities, selection of G6PD confirmatory centers, confirmatory reference laboratories for hemoglobinopathies and for metabolic disorders; to the establishment of NBS Continuity Clinics that would handle the long-term follow-up management of confirmed patients.
Likewise, NSRC assumes leadership role in examining the totality of the NBS system thus, facilitating the review and evaluation of issues and challenges facing the newborn screening system and ultimately obtaining/coming up with recommendations to strengthen the program. It collaborates with DOH in the monitoring of program implementation in seventeen (17) DOH-Centers for Health Development, twenty-nine (29) G6PD Confirmatory Centers, and fourteen (14) Newborn Screening Continuity Clinics, aside from processing applications of Newborn Screening Facilities which now totals to more than 7000. With these facilities in place, confirmed cases of G6PD deficiencies were detected in 248,000 children, 5,571 with congenital hypothyroidism, 738 with congenital adrenal hyperplasia, 186 with maple syrup urine disease, 150 with galactosemia, and 122 with phenylketonuria. To sustain the NSRC’s efforts, it is instrumental in ensuring that the key implementers of the program in the different levels are equipped through capability building initiatives in all aspects of the program. NSRC holds regular training for management teams of the Newborn Screening Centers (NSCs) and Continuity Clinics.
NSRC is the principal repository of technical information relating to newborn screening standards and practices as well as the office mandated to oversee the content of educational materials. It holds the critical task of overseeing the national database of patients tested and the registry for each condition tested which shall be utilized to develop a plan for long-term outcome evaluation.
It continuously facilitates the undertaking of researches relevant to the improvement of the NBS system and research outputs leading to new knowledge that may become basis for policy changes on newborn screening implementation. An offshoot of this was the expansion of screening from six (6) to more than twenty-eight (28) disorders. It supports an international collaboration (Cebu Declaration 2008, Manila Declaration 2010, Manila Declaration 2012, Cebu Declaration 2013, Penang Declaration 2015, and Ulanbataar Declaration 2017) signed by 11 countries to facilitate the development of newborn systems in the Asia Pacific Region.
NSRC is an ISO 9001:2015-certified institution. It is working to reach the target that NSCs are ISO 15189-certified by 2030 per the National Policy and Strategic Framework on Expanded Newborn Screening for 2017-2030.
NSRC is responsible for ensuring good laboratory practice standards for NSCs through formulation of laboratory and follow-up protocols, the establishment of external laboratory proficiency testing and certification programs, provision of technical expertise, and the conduct of external audits and other quality assurance activities. Currently, there are seven (7) NSCs nationwide. NSCs will be set-up soon in Mindanao and Bicol.
EXISTING SERVICES AND PROJECTS:
Program Review
- Program Implementation Review of CHDs
- NSCs
- External audit of all NSCs
- Continuation of Accreditation of NSC-NIH, NSC-V, and NSC-SL
- Long-Term and Short-Term Follow-up
- Program Implementation Review of NBSCCs
- Short-term Case audits (NSCs)
- Long-term Case audits (NBSCCs)
- Monitoring of G6PDCCs
Quality Assurance
- Development of Standard Manuals
- Review of NBS data
- Review of Data and Algorithms
- Laboratory Proficiency
- Follow-up Team/LIMS meeting
- Evaluation of New Reagents/ Method
Patient Care
- Conduct of PSPME Follow-up clinics
- Establishment of NBSCC satellite clinics
Laboratory Set-up
- Establishment of New G6PDCCs
- Setting-up of NSRC Lab
Capacity Building
- Training on CMS/Writeshop on Action Mapping
- Training of Nutritionists and Dietitians per region
- Development/Writeshops of/on Additional Competency-Based Assessment Tools
- Training of CHD Coordinators
- Conduct of Training related to Quality Assurance
- Conduct of Management Reviews with NSC Hosts
- Conduct of ISO-related Activities including ISO 15189
Awareness and Advocacy
- Launching of the Facility Engagement Web Application
- Development of NBS Series Videos
- Development of Materials for NBS Week
- Enhancement of the www.newbornscreening.ph website
- Updating and Revisions of Existing IEC Materials
- Development of New IEC Materials
- Conduct of Digital Media Campaigns
- Event Partnerships
Information Management Systems
- Continuous Processing of New NSF Applications
- Processing of Renewal Stickers and DOH NBS Certificates
- Updating of NSF Active and Inactive Lists
- Continuous Consolidation of NBS-Related Databases
- Release of Annual Statistical Report
- Development of Program Online Monitoring Performance Tool
- Development of EQAS/PT Online System
- Launching of NBS Dashboard
- Disease Mapping
- Conduct of IT Audit
- Planning for Shift of Laboratory Information Management System
CURRENT RESEARCHES:
RGAO Number |
Title |
Primary Investigator |
Remarks |
NBS Congenital Hypothyroidism Research Program |
|||
RGAO-2019-0238 |
Predictive Factors of Transient Congenital Hypothyroidism: A Retrospective Study |
Lorna F. Ramos-Abad, MD Department of Pediatrics Philippine General Hospital |
Recommended for funding; noted with SJREB ethics review, to be endorsed to RGAO for MOA preparation |
RGAO-2021-0409
|
Prevalence of Transient Congenital Hypothyroidism among Filipino newborns
|
Lorna F. Ramos-Abad, MD Department of Pediatrics Philippine General Hospital
|
Recommended for funding; for ethics review, to be endorsed to RGAO for MOA preparation once with ethics approval |
RGAO-2019-0098
|
Genetic Characterization among children with Congenital Hypothyroidism in the Philippines
|
Lorna F. Ramos-Abad, MD Department of Pediatrics Philippine General Hospital
|
Recommended for funding; for revision of proposal and ethics review, to be endorsed to RGAO for MOA preparation once with ethics approval |
Health Promotion and Advocacy Research Program |
|||
RGAO-2021-0559 |
Social Media Content Analysis of Public Glucose-6-Phosphate Deficiency (G6PD) Facebook Groups |
Ebner Bon G. Maceda, MD Institute of Human Genetics National Institutes of Health |
Recommended for funding; noted with ethics review, to be endorsed to RGAO for MOA preparation |
RGAO-2021-0560 |
A Content Analysis of Facebook Groups on Congenital Adrenal Hyperplasia |
Cheryll J. Magbanua-Calalo, MD Newborn Screening Reference Center National Institutes of Health |
Recommended for funding; ongoing ethics review, to be endorsed to RGAO for MOA preparation once with ethics approval |
RGAO-2021-0561 |
Social media content analysis of public maple syrup urine disease (MSUD) Facebook groups |
Michelle E. Abadingo, MD NSRC- Newborn Screening Reference Center National Institutes of Health |
Recommended for funding; for ethics review, to be endorsed to RGAO for MOA preparation once with ethics approval |
NBS Metabolic Disorder Research Program |
|||
RGAO-2021-0385 |
Acceptability and Sustainability of Dried Blood Spot collection by Primary Caregivers of Filipino patients with MSUD and PKU |
Roxanne Janica Merencilla Institute of Human Genetics National Institutes of Health |
Recommended for funding pending revisions
|
Visit www.newbornscreening.ph for more information.
Institute/Center administration:
Director: Michelle E. Abadingo, MD
Office Address: National Institutes of Health Building, UP Manila